{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T01:16:42Z","timestamp":1782436602793,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10067-024-07238-2","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T08:57:25Z","timestamp":1733734645000},"page":"299-304","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Barnidipine as a potential alternative treatment for Raynaud's phenomenon secondary to systemic sclerosis: a retrospective pilot study"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9335-3371","authenticated-orcid":false,"given":"Riccardo","family":"Bixio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3225-2152","authenticated-orcid":false,"given":"Francesca","family":"Mastropaolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6967-7805","authenticated-orcid":false,"given":"Matteo","family":"Appoloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5901-7742","authenticated-orcid":false,"given":"Davide","family":"Bertelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5678-3161","authenticated-orcid":false,"given":"Eugenia","family":"Bertoldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8653-7858","authenticated-orcid":false,"given":"Andrea","family":"Morciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1256-0761","authenticated-orcid":false,"given":"Stefano","family":"Di Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8915-0755","authenticated-orcid":false,"given":"Giovanni","family":"Adami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1917-5655","authenticated-orcid":false,"given":"Ombretta","family":"Viapiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9692-2293","authenticated-orcid":false,"given":"Maurizio","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7254-4686","authenticated-orcid":false,"given":"Idolazzi","family":"Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,9]]},"reference":[{"key":"7238_CR1","doi-asserted-by":"publisher","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore Y, Simms R, Distler O et al (2015) Systemic sclerosis. Nat Rev Dis Primer 1:15002. https:\/\/doi.org\/10.1038\/nrdp.2015.2","journal-title":"Nat Rev Dis Primer"},{"key":"7238_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/rheumatology\/key026","volume":"58","author":"JD Pauling","year":"2019","unstructured":"Pauling JD, Saketkoo LA, Matucci-Cerinic M et al (2019) The patient experience of Raynaud\u2019s phenomenon in systemic sclerosis. Rheumatology 58:18\u201326. https:\/\/doi.org\/10.1093\/rheumatology\/key026","journal-title":"Rheumatology"},{"key":"7238_CR3","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","volume":"76","author":"O Kowal-Bielecka","year":"2017","unstructured":"Kowal-Bielecka O, Fransen J, Avouac J et al (2017) Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis 76:1327\u20131339. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209909","journal-title":"Ann Rheum Dis"},{"key":"7238_CR4","doi-asserted-by":"publisher","first-page":"CD000467","DOI":"10.1002\/14651858.CD000467.pub2","volume":"12","author":"F Rirash","year":"2017","unstructured":"Rirash F, Tingey PC, Harding SE et al (2017) Calcium channel blockers for primary and secondary Raynaud\u2019s phenomenon. Cochrane Database Syst Rev 12:CD000467. https:\/\/doi.org\/10.1002\/14651858.CD000467.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"7238_CR5","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1016\/S2665-9913(19)30079-7","volume":"1","author":"C Khouri","year":"2019","unstructured":"Khouri C, Lepelley M, Bailly S et al (2019) Comparative efficacy and safety of treatments for secondary Raynaud\u2019s phenomenon: a systematic review and network meta-analysis of randomised trials. Lancet Rheumatol 1:e237\u2013e246. https:\/\/doi.org\/10.1016\/S2665-9913(19)30079-7","journal-title":"Lancet Rheumatol"},{"key":"7238_CR6","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2165\/00003495-200161070-00007","volume":"61","author":"HS Malhotra","year":"2001","unstructured":"Malhotra HS, Plosker GL (2001) Barnidipine. Drugs 61:989\u2013996. https:\/\/doi.org\/10.2165\/00003495-200161070-00007","journal-title":"Drugs"},{"key":"7238_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40292-016-0177-9","volume":"24","author":"R Lins","year":"2017","unstructured":"Lins R, Haerden Y, de Vries C (2017) Replacement of Amlodipine and Lercanidipine by Barnidipine: Tolerability and Effectiveness in a Real-Life Study. High Blood Press Cardiovasc Prev 24:29\u201336. https:\/\/doi.org\/10.1007\/s40292-016-0177-9","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"7238_CR8","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 72:1747\u20131755. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204424","journal-title":"Ann Rheum Dis"},{"key":"7238_CR9","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/rheumatology\/37.9.952","volume":"37","author":"CM Black","year":"1998","unstructured":"Black CM, Halkier-S\u00f8rensen L, Belch JJ et al (1998) Oral iloprost in Raynaud\u2019s phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study. Br J Rheumatol 37:952\u2013960. https:\/\/doi.org\/10.1093\/rheumatology\/37.9.952","journal-title":"Br J Rheumatol"},{"key":"7238_CR10","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1136\/ard.2009.107706","volume":"69","author":"PP Khanna","year":"2010","unstructured":"Khanna PP, Maranian P, Gregory J, Khanna D (2010) The minimally important difference and patient acceptable symptom state for the Raynaud\u2019s condition score in patients with Raynaud\u2019s phenomenon in a large randomised controlled clinical trial. Ann Rheum Dis 69:588\u2013591. https:\/\/doi.org\/10.1136\/ard.2009.107706","journal-title":"Ann Rheum Dis"},{"key":"7238_CR11","doi-asserted-by":"publisher","first-page":"152087","DOI":"10.1016\/j.semarthrit.2022.152087","volume":"57","author":"M Roustit","year":"2022","unstructured":"Roustit M, Jullien A, Jambon-Barbara C et al (2022) Placebo response in Raynaud\u2019s Phenomenon clinical trials: The prominent role of regression towards the mean: Placebo response in Raynaud\u2019s Phenomenon. Semin Arthritis Rheum 57:152087. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152087","journal-title":"Semin Arthritis Rheum"},{"key":"7238_CR12","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.semarthrit.2020.06.018","volume":"50","author":"JD Pauling","year":"2020","unstructured":"Pauling JD, Hackett N, Guida A, Merkel PA (2020) Performance of laser-derived imaging for assessing digital perfusion in clinical trials of systemic sclerosis-related digital vasculopathy: A systematic literature review. Semin Arthritis Rheum 50:1114\u20131130. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.06.018","journal-title":"Semin Arthritis Rheum"},{"key":"7238_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/080370598438573","volume":"1","author":"JW van der Velden","year":"1998","unstructured":"van der Velden JW, Beudeker HJ, Nishi M (1998) Diversity and intensity of adverse events in the treatment of hypertension with barnidipine. Blood Press Suppl 1:27\u201329. https:\/\/doi.org\/10.1080\/080370598438573","journal-title":"Blood Press Suppl"},{"key":"7238_CR14","doi-asserted-by":"publisher","first-page":"152268","DOI":"10.1016\/j.semarthrit.2023.152268","volume":"63","author":"M Di Battista","year":"2023","unstructured":"Di Battista M, Wasson CW, Alcacer-Pitarch B, Del Galdo F (2023) Autonomic dysfunction in systemic sclerosis: A scoping review. Semin Arthritis Rheum 63:152268. https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152268","journal-title":"Semin Arthritis Rheum"},{"key":"7238_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10067-023-06796-1","volume":"43","author":"L Ross","year":"2024","unstructured":"Ross L, Hansen D, Maltez N et al (2024) The effect of calcium channel blockers on digital ulcers in systemic sclerosis: data from a prospective cohort study. Clin Rheumatol 43:269\u2013276. https:\/\/doi.org\/10.1007\/s10067-023-06796-1","journal-title":"Clin Rheumatol"},{"key":"7238_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s13075-019-2080-y","volume":"21","author":"K Morrisroe","year":"2019","unstructured":"Morrisroe K, Stevens W, Sahhar J et al (2019) Digital ulcers in systemic sclerosis: their epidemiology, clinical characteristics, and associated clinical and economic burden. Arthritis Res Ther 21:299. https:\/\/doi.org\/10.1186\/s13075-019-2080-y","journal-title":"Arthritis Res Ther"},{"key":"7238_CR17","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1007\/s10067-023-06511-0","volume":"42","author":"I Sagonas","year":"2023","unstructured":"Sagonas I, Daoussis D (2023) Treatment of digital ulcers in systemic sclerosis: recent developments and future perspectives. Clin Rheumatol 42:2589\u20132599. https:\/\/doi.org\/10.1007\/s10067-023-06511-0","journal-title":"Clin Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07238-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07238-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07238-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T13:39:33Z","timestamp":1736775573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07238-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,9]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["7238"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07238-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,9]]},"assertion":[{"value":"26 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The lead author (the manuscript\u2019s guarantor) affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Transparency declaration"}},{"value":"The studies involving human participants were reviewed and approved by our local Ethics Committee (Verona, Italy). The study was conducted within protocol 1483CESC, per the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all individual participants included. The patients\/participants provided their written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical and consent statements"}},{"value":"All authors have completed the ICMJE uniform disclosure form at  (available on request from the corresponding author) and declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}